SCHEMBL29307756

SCHEMBL29307756

CCN(C)Cc1ccc(C2(c3ccccc3)c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.45
▸ LMNA P02545 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ OPRK1 P41145 1/20 0.45
▸ MAOB P27338 2/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ CHRNB2 P17787 1/20 0.38
▸ CHRNA4 P43681 1/20 0.38
▸ LTA4H P09960 1/20 0.37
▸ CARM1 Q86X55 1/20 0.37
▸ PRMT6 Q96LA8 1/20 0.37
▸ PRMT8 Q9NR22 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ PYCR1 P32322 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29307757 0.87 KMT2A (0.42) KMT2ALMNAMEN1SMN1; SMN2KDM4E
SCHEMBL17903074 0.86 KMT2A (0.46) KMT2ALMNAMEN1SMN1; SMN2KDM4E
SCHEMBL29307758 0.82 KMT2A (0.38) KMT2ALMNAMEN1SMN1; SMN2KDM4E
SCHEMBL19735229 0.81 ALDH1A1 (0.46) KMT2ALMNAMEN1SMN1; SMN2KDM4E
SCHEMBL19735231 0.81 ALDH1A1 (0.46) KMT2ALMNAMEN1SMN1; SMN2KDM4E
SCHEMBL20414401 0.80 SMN1; SMN2 (0.53) KMT2ALMNAMEN1SMN1; SMN2KDM4E
SCHEMBL8984806 0.77 MAPT (0.57) KMT2ALMNAMEN1SMN1; SMN2KDM4E
SCHEMBL30561153 0.77 MEN1 (0.57) KMT2ALMNAMEN1SMN1; SMN2KDM4E
SCHEMBL2790658 0.77 MEN1 (0.57) KMT2ALMNAMEN1SMN1; SMN2KDM4E
SCHEMBL17903068 0.77 HTR1A (0.42) KMT2ALMNAMEN1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12041847-B2 Compound for organic electric element, organic electric element using the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12041847-B2 Compound for organic electric element, organic electric element using the same, and electronic device thereof ORAI2, OR51E2, OR10J3 KMT2A 662/4885LMNA 2446/4885MEN1 1072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback